Funding for this research was provided by:
MERU Foundation, Italy
Deutsche Forschungsgemeinschaft SFB 1292
First Online: 22 October 2021
: Z.M.R. is the founder, president and CEO of MERU VasImmune (a company that develops coagulation tests). W.R. is affiliated with MERUVasImmune and reports intellectual property and royalty income from ARCA biopharma (for the treatment of COVID-19-associated coagulopathy).
Free to read: This content has been made available to all.